BGI Diagnosis (short for Shenzhen BGI Diagnosis Technology Co., Ltd.), a subsidiary of BGI, is a clinical medicine platform built to use human genome research results for health relying on the cutting-edge technologies of BGI. With comprehensive coverage of the “4P medicine” practice (Predictive, Preventive, Participatory and Personalized), it is committed to build genetic testing standards and promote clinical application of genetic technology so as to reduce birth defects and preventing major diseases.
With the high-throughput sequencing device, mass spectrometer and high-performance informatics center, BGI Diagnosis has developed advanced genetic testing techniques for a number of diseases such as Down's syndrome and other chromosomal disorders, monogenic disorder, hereditary deafness, thalassemia, newborn genetic metabolic diseases, leukemia, cervical cancer and hepatitis; it also has developed the genetic testing and diagnostic technology system covering life cycle and features significant advantages in sensitivity, accuracy and safety.
Headquartered in Shenzhen, BGI Diagnosis has set up business centers throughout Europe, America and Asia-Pacific with service network around the world. So far, it has erated with many domestic and international medical organizations to provide high quality testing services.
1)To serve the wellbeing of human with the high-throughput, cost effective, omics platform.
2)Be the world’s leader in healthcare, establish industrial standard, using “Big Data” to serve “Big” Science and provide “Population-based” healthcare solution.
For more information, please visit Official Website of BGI Diagnosis.
Qualification and Certification
Medical Institutions Practicing License for Shenzhen BGI Unicare Clinic
Medical Institutions Practicing License for Wuhan BGI Medical Laboratory
Medical Institutions Practicing License for Medical Laboratory of Tianjin BGI Technology Co., Ltd
Certifications of Next Generation Sequencing Diagnostic Products(CFDA Arppoved)
Headquartered in Shenzhen, BGI Diagnosis cooperates with over 1000 leading hospitals in the world, including Americas, Europe, Asia Pacific, Japan, Hong Kong, and Beijing, Tianjin, Shanghai, Hangzhou, Wuhan, Guangzhou of mainland China.
- [news]BGI Diagnosis Obtained the Compliance Certificate of U.S. FDA 21 CFR Part 11
- [news]BGI Europe and Genomed Sign Strategic Partnership to Introduce NIFT Test to Poland
- [news]CFDA Approved Next Generation Sequencing Diagnostic Products
- [news]BGI Health(BGI Diagnosis) Forms Partnership with University of Mayor in South America
- [news]Lord Mayor of Copenhagen Ayfer Baykal Visits BGI’s European Genome Research Center
- [news]Complete Genomics and BGI-Shenzhen Announce Definitive Agreement to Merge
Tel: +45 7026 0806
Address: Ole Maaløes Vej 3, 2200 København N, Copenhagen, Denmark
Shenzhen BGI Unicare Clinic
Tel: +86-0755-25254419 / +86-0755-25254395
Address: No.2, Wangcui Road, Dameisha, Yantian District, Shenzhen (5F and 6F of Meishan Hospital)